(Q58000796)
Statements
Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial (English)
Jürgen K Rockstroh
Franco Maggiolo
Aza Rakhmanova
Patrick Yeni
Benjamin Young
Steve Almond
Ivy Song
Cindy Brothers
Sherene Min